<unk> , sold under the brand name Evotaz, is a fixed-dose combination antiretroviral medication used to treat and prevent HIV/AIDS. It contains atazanavir and<unk> . Atazanavir is an HIV protease inhibitor and<unk>  is an inhibitor of cytochrome P450 (CYP) enzymes of the CYP3A family.<unk>  was approved by the Food and Drug Administration (FDA) for medical use in United States in January 2015. It was approved for medical use in the European Union in July 2015.
Atazanavir/cobicistat
Darunavir/cobicistat
Atazanavir/ritonavir
Elbasvir/grazoprevir
Cabotegravir/rilpivirine
Nirmatrelvir/ritonavir
Ombitasvir/paritaprevir/ritonavir
Dolutegravir/rilpivirine